  Brain metastases occur frequently in patients with metastatic cancer. Early
and accurate detection of brain metastases is very essential for treatment
planning and prognosis in radiation therapy. To improve brain metastasis
detection performance with deep learning, a custom detection loss called
volume-level sensitivity-specificity (VSS) is proposed, which rates individual
metastasis detection sensitivity and specificity in (sub-)volume levels. As
sensitivity and precision are always a trade-off in a metastasis level, either
a high sensitivity or a high precision can be achieved by adjusting the weights
in the VSS loss without decline in dice score coefficient for segmented
metastases. To reduce metastasis-like structures being detected as false
positive metastases, a temporal prior volume is proposed as an additional input
of DeepMedic. The modified network is called DeepMedic+ for distinction. Our
proposed VSS loss improves the sensitivity of brain metastasis detection for
DeepMedic, increasing the sensitivity from 85.3% to 97.5%. Alternatively, it
improves the precision from 69.1% to 98.7%. Comparing DeepMedic+ with DeepMedic
with the same VSS loss, 44.4% of the false positive metastases are reduced in
the high sensitivity model and the precision reaches 99.6% for the high
specificity model. The mean dice coefficient for all metastases is about 0.81.
With the ensemble of the high sensitivity and high specificity models, on
average only 1.5 false positive metastases per patient needs further check,
while the majority of true positive metastases are confirmed. The ensemble
learning is able to distinguish high confidence true positive metastases from
metastases candidates that require special expert review or further follow-up,
being particularly well-fit to the requirements of expert support in real
clinical practice.
